Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
about
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East AsiaMalaria in the Greater Mekong Subregion: heterogeneity and complexityImplementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 periodAntimalarial drug quality in the most severely malarious parts of Africa - a six country studyResponding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practiceThe global threat of counterfeit drugs: why industry and governments must communicate the dangersMalaria Diagnosis Across the International Centers of Excellence for Malaria Research: Platforms, Performance, and StandardizationThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsSubstandard/counterfeit antimicrobial drugsMalaria transmission and disease burden in Assam: challenges and opportunitiesA poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appealQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainAssessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLabĀ®: a field studyMolecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesPrevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional dataManslaughter by fake artesunate in Asia--will Africa be next?A nationwide survey of the quality of antimalarials in retail outlets in TanzaniaApplication of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.Guidelines for field surveys of the quality of medicines: a proposal.Application of loop analysis for evaluation of malaria control interventions.The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, IndonesiaAnti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findings.Retail sector distribution chains for malaria treatment in the developing world: a review of the literatureAssessing the quality of service of village malaria workers to strengthen community-based malaria control in Cambodia.The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India.Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin.Substandard drugs: a potential crisis for public health.Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya.Evaluation of the quality of artemisinin-based antimalarial medicines distributed in ghana and togoPutting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.Artemisinin Antimalarials: Preserving the "Magic Bullet"Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risksDiscovery, mechanisms of action and combination therapy of artemisininMalaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulationsMedicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials.A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better
P2860
Q21032452-B7A48981-A6A8-4C33-A350-F5FB6ABF0AFAQ21032492-A137E061-BBF5-43B5-9173-303E91CC07CFQ21034060-47585B90-859F-4165-8E87-08A364A599C5Q21092213-83A35F51-EF04-458F-BBCE-BCE33DAEB123Q21092381-F5EDDF50-0EA8-4478-B060-94228EDA3206Q24795733-A8F68A96-6A97-4231-8EC6-88A4D1A9451FQ26799721-445F2558-B44C-401A-9FE1-4264786FAE6FQ26828002-5045C84C-42EE-44E0-A902-DF95B18BFD35Q27000750-A6C0EBD0-78BD-4DFE-AD14-B282C383B5D8Q27009319-B55D6589-9E8B-429F-85BC-8606CEA9C217Q28483958-E66E4484-C7A2-4B26-9EF6-17F377319046Q28483975-F5B5BB47-B4AB-4E3F-8D14-350E006166EFQ28538830-939FD7BB-7B22-4655-BB8D-F11DA5137411Q28647142-B6CAAC52-AC5C-4A7A-809C-7C2D0EA7E508Q30568502-9A4EC0A1-C08F-4035-B2E0-55AEE48B37FEQ31125988-AF0273FA-9270-49A5-8D68-25CD0BE108EEQ33245718-EAD155DC-DB6B-4CCE-8DF1-23FFBC5302C1Q33377031-DB0EB912-2404-478E-9FE6-53C38B849856Q33400567-5050726F-7BF8-46EE-A3E6-472F7FEAE0A9Q33422019-3400E908-DD72-41B0-8E2A-FFA01F0B500AQ33597968-2A406E19-41F0-4E67-B86A-0509F61F6DCCQ33601072-0B6B8351-6129-4978-8069-AFC4C42EF3D5Q33629491-F4EE32B6-A5C2-4BBC-AC98-9E7D3BC06022Q33691830-91B0A6FA-A921-45D9-80B0-D90130CD2BFEQ33718659-CAAD53DB-8FD8-4C6B-B895-2AC0E3DB6774Q33864521-A48B83D6-C5E9-40D7-83AD-686E53D56116Q33950863-EB0821A9-5947-4B44-AA21-CBAC3F8D07E8Q33960081-57AFDCA9-8F42-4933-A6BA-072626CEEF46Q34065256-FB93B2C9-0711-4F36-849B-63DC8AAB3FABQ34315195-D50DBF5F-6552-4753-854E-70F6C61FA4D7Q34479443-D314356B-E5F9-49BC-808C-B67C173576A8Q34557276-F5ACB646-E144-4A36-A001-96579A5F00E4Q34622342-0911CB94-CD65-479E-80B6-BFD5DF3EB1EBQ34752802-36861DCE-0408-47D8-8816-D6A41464C8DEQ35006418-784245ED-B714-4E87-A02B-3D01846C3B43Q35079965-44E90E98-2403-4DA0-927C-D47EB036A453Q35101269-BC314F07-6C9B-49DC-9F12-2CF70FC49BE0Q35207264-81E31D66-7013-43E8-9A94-9B20A5965272Q35663437-CB8A0F7F-108E-407F-BFA4-644032EBC6DBQ35681772-0B29B88B-4F83-45B4-94E2-EB5D3C104FFF
P2860
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004幓ć®č«ę
@ja
2004幓å¦ęÆęē«
@wuu
2004幓å¦ęÆęē«
@zh-cn
2004幓å¦ęÆęē«
@zh-hans
2004幓å¦ęÆęē«
@zh-my
2004幓å¦ęÆęē«
@zh-sg
2004幓åøč”ęē«
@yue
2004幓åøč”ęē«
@zh
2004幓åøč”ęē«
@zh-hant
name
Fake antimalarials in Southeas ...... valence of fake antimalarials.
@en
type
label
Fake antimalarials in Southeas ...... valence of fake antimalarials.
@en
prefLabel
Fake antimalarials in Southeas ...... valence of fake antimalarials.
@en
P2093
P2860
P50
P1476
Fake antimalarials in Southeas ...... valence of fake antimalarials.
@en
P2093
Dondorp AM
Smithuis FM
Van Damme W
P2860
P304
P356
10.1111/J.1365-3156.2004.01342.X
P577
2004-12-01T00:00:00Z